Global Cancer Registry Software Market Size study & Forecast, by Type (Standalone Software, Integrated Software), by Deployment Model (On-Premise, Cloud-Based), by Database Type (Commercial Database, Public Database), By Functionality (Cancer Reporting to Meet State and Federal Regulations, Patient Care Management, Medical Research & Clinical Studies, Product Outcome Evaluation), by End-User (Government Organizations & Third-Party Administrators, Hospitals & Medical Practices, Private Players, Pharmaceutical, Biotechnology, and Medical Device Companies, Research Centers) and Regional Analysis, 2022-2029
Global Cancer Registry Software Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Cancer registry is a computerized database which uses software solutions to organize, gather and store data of the cancer patients and evaluate cancer-specific upshots, situations and drug/medical device exposure. Growing number of cancer cases, increasing adoption of EHR, favorable government programs towards cancer and growing use of cancer patient registry data for post-marketing surveillance are the few factors responsible for high CAGR of the market over the forecast period.
The rising number of cancer cases globally support the market growth because it helps in automates data gathering for federal and state registries, which aids in tracking the efficacy of various treatment options. Additionally, the information gathered by the state registers assists in a better understanding and treatment of the disease. For instance, according to International Agency for Research on Cancer (IARC), approx. 19.3 million new cases of cancer are reported in UN regions in 2020. In the year 2040, it is anticipated that there would be about 28.4 million incident cases. Additionally, increasing number of accountable care organizations is anticipated to create the lucrative opportunity for the marker during forecast period. However, the privacy and data security-related concerns may stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Cancer Registry Software Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising prevalence of cancer, government funding initiatives to encourage the development of cancer registries and high investments in healthcare IT across the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising prevalence of cancer, rising public private investment for healthcare infrastructure development would create lucrative growth prospects for the Cancer Registry Software market across Asia Pacific region.
Major market player included in this report are:
Elekta
Electronic Registry Systems, Inc.
Onco, Inc.
C/NET Solutions
Rocky Mountain Cancer Data Systems
McKesson Corporation
IBM Corporation
Ordinal Data Inc.
Himagine Solutions Inc.
CONDUENT Inc.
Recent Developments in the Market:
In June 2020, Arbor Metrix Inc., situated in the United States, and the Society of Interventional Radiology (SIR) have collaborated. With the help of this collaboration, the IR Quality Registry will be made accessible, allowing analytics to be incorporated to enhance patient care.
Global Cancer Registry Software Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Deployment Model, Database Type, Functionality, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:
By Type:
Standalone Software
Integrated Software
By Deployment Model:
On-Premise
Cloud-Based
By Database Type:
Commercial Database
Public Database
By Functionality:
Cancer Reporting to Meet State and Federal Regulations
Patient Care Management
Medical Research & Clinical Studies
Product Outcome Evaluation
By End-User:
Government Organizations & Third-Party Administrators
Hospitals & Medical Practices
Private Players
Pharmaceutical, Biotechnology, and Medical Device Companies
Research Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Companies Mentioned
Elekta
Electronic Registry Systems, Inc.
Onco, Inc.
C/NET Solutions
Rocky Mountain Cancer Data Systems
McKesson Corporation
IBM Corporation
Ordinal Data Inc.
Himagine Solutions Inc.
CONDUENT Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook